Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telithromycin versus azithromycin in children with acute otitis media
2014-004637-47Phase 3
- Sponsor
- Sanofi
- Start
- Mar 2015
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute otitis media (AOM) and purulent otitis media comparing Telithromycin with Azithromycin (2 arms). Primary endpoints: Clinical outcome in per-protocol clinical population and Time to symptom resolution.
02
Drugs
telithromycinazithromycin
03
Conditions
acute otitis media (AOM)purulent otitis media
Beyond the preview
Go deeper on 2014-004637-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004637-47.